ATE258927T1 - Verbessertes verfahren zur herstellung von n- substituierte aminotetraline - Google Patents

Verbessertes verfahren zur herstellung von n- substituierte aminotetraline

Info

Publication number
ATE258927T1
ATE258927T1 AT00978699T AT00978699T ATE258927T1 AT E258927 T1 ATE258927 T1 AT E258927T1 AT 00978699 T AT00978699 T AT 00978699T AT 00978699 T AT00978699 T AT 00978699T AT E258927 T1 ATE258927 T1 AT E258927T1
Authority
AT
Austria
Prior art keywords
producing
improved process
aminotetralines
substituted
substituted aminotetralines
Prior art date
Application number
AT00978699T
Other languages
English (en)
Inventor
Gevork Minaskanian
Keith Rippel
Original Assignee
Aderis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aderis Pharmaceuticals Inc filed Critical Aderis Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE258927T1 publication Critical patent/ATE258927T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AT00978699T 1999-11-23 2000-11-16 Verbessertes verfahren zur herstellung von n- substituierte aminotetraline ATE258927T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16700999P 1999-11-23 1999-11-23
PCT/US2000/031415 WO2001038321A1 (en) 1999-11-23 2000-11-16 Improved process for preparing nitrogen-substituted aminotetralins

Publications (1)

Publication Number Publication Date
ATE258927T1 true ATE258927T1 (de) 2004-02-15

Family

ID=22605581

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00978699T ATE258927T1 (de) 1999-11-23 2000-11-16 Verbessertes verfahren zur herstellung von n- substituierte aminotetraline

Country Status (15)

Country Link
US (1) US6372920B1 (de)
EP (1) EP1232152B1 (de)
CN (1) CN1185225C (de)
AR (1) AR026505A1 (de)
AT (1) ATE258927T1 (de)
AU (1) AU1613101A (de)
CA (1) CA2392563C (de)
DE (1) DE60008136T2 (de)
DK (1) DK1232152T3 (de)
ES (1) ES2216992T3 (de)
HK (2) HK1049156B (de)
PL (1) PL202805B1 (de)
PT (1) PT1232152E (de)
TR (1) TR200400401T4 (de)
WO (1) WO2001038321A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE10041479A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
DE10261696A1 (de) * 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10359528A1 (de) * 2003-12-18 2005-07-28 Schwarz Pharma Ag (S)-2-N-Propylamino-5-hydroxytetralin als D3-agonistisches Therapeutikum
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
TWI392670B (zh) * 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
EP1987815A1 (de) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Im Mund-Nasen-Rachenraum verabreichbare pharmazeutische Zusammensetzungen enthaltend Dopaminagonisten zur Vorbeugung und/oder Behandlung von unruhigen Gliedmassen
WO2008146284A2 (en) * 2007-05-30 2008-12-04 Chemagis Ltd. Crystalline rotigotine base and preparation process therefor
WO2009053697A1 (en) * 2007-10-26 2009-04-30 Pliva Hrvatska D.O.O. Polymorphic forms of ( s ) -rotigotine hydrochloride
WO2009056791A1 (en) * 2007-11-02 2009-05-07 Pliva Hrvatska D.O.O. Processes for preparing pharmaceutical compounds
US8592477B2 (en) * 2007-11-28 2013-11-26 Ucb Pharma Gmbh Polymorphic form of rotigotine and process for production
US20090202647A1 (en) * 2008-02-11 2009-08-13 Mayur Devjibhai Khunt Solid form of racemic rotigotine
IT1392387B1 (it) * 2008-09-26 2012-03-02 Solmag S P A Ora Fidia Farmaceutici S P A Processo per la preparazione di rotigotina
MX2011005979A (es) 2008-12-09 2011-06-27 Interquim Sa Procedimiento de obtencion de (6s)-(-)-5,6,7,8-tetrahidro-6-[propi l-(2-tienil)etil]amino-1-naftol(rotigotina).
WO2010073124A2 (en) 2008-12-26 2010-07-01 Actavis Group Ptc Ehf Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
EP2281559A1 (de) 2009-06-26 2011-02-09 UCB Pharma GmbH Pharmazeutische Zusammensetzung enthaltend Rotigotin (Salze oder Na), insbesondere für Iontophorese
CN102010400B (zh) 2009-09-07 2015-02-04 药源药物化学（上海）有限公司 S-5-取代-n-2'-(噻吩-2-基-)乙基-1,2,3,4-四氢萘-2-胺或其手性酸盐和用于制备罗替戈汀
EP2490673A2 (de) 2009-10-19 2012-08-29 Actavis Group Ptc Ehf Amorphe rotigotin-copräzipitate
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
DK2515887T3 (en) 2009-12-22 2018-09-17 Ucb Biopharma Sprl Polyvinylpyrrolidone to stabilize a solid dispersion of the non-crystalline form of rotigotine
EP2531486B1 (de) 2010-02-05 2017-06-21 UCB Biopharma SPRL Neues verfahren für die herstellung von stickstoffsubstituierten aminotetralinderivaten
AU2011268871C1 (en) * 2010-06-25 2015-06-04 Ucb Pharma Gmbh Processes for the resolution of nitrogen substituted (S) - 5 -alkoxy- 2 -aminotetralin derivatives
ES2626024T3 (es) 2011-06-27 2017-07-21 Shan Dong Luye Pharmaceutical Co., Ltd. Procedimiento para preparar industrialmente amino-5,6,7,8-tetrahidronaftol sustituido con nitrógeno
CN103768043B (zh) * 2012-10-22 2015-12-09 苏州药明康德新药开发股份有限公司 采用羟丙基-β-环糊精配制四氢化萘类化合物均一稳定溶液的方法
US10611749B2 (en) 2018-02-15 2020-04-07 Solara Active Pharma Sciences Limited Process for preparation of Rotigotine and intermediates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0026848B1 (de) 1979-09-14 1983-05-04 Sandoz Ag Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten
US4564628A (en) 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
US4968837A (en) 1989-07-28 1990-11-06 Ethyl Corporation Resolution of racemic mixtures
US5382596A (en) * 1993-08-05 1995-01-17 Whitby Research, Inc. Substituted 2-aminotetralins

Also Published As

Publication number Publication date
CA2392563A1 (en) 2001-05-31
CA2392563C (en) 2011-02-15
PL202805B1 (pl) 2009-07-31
TR200400401T4 (tr) 2004-03-22
DE60008136D1 (de) 2004-03-11
CN1391569A (zh) 2003-01-15
HK1052514A1 (zh) 2003-09-19
AR026505A1 (es) 2003-02-12
PL355607A1 (en) 2004-05-04
US6372920B1 (en) 2002-04-16
EP1232152B1 (de) 2004-02-04
DE60008136T2 (de) 2004-09-09
EP1232152A1 (de) 2002-08-21
CN1185225C (zh) 2005-01-19
AU1613101A (en) 2001-06-04
DK1232152T3 (da) 2004-04-05
WO2001038321A1 (en) 2001-05-31
ES2216992T3 (es) 2004-11-01
PT1232152E (pt) 2004-06-30
HK1049156B (zh) 2004-12-10
HK1049156A1 (en) 2003-05-02

Similar Documents

Publication Publication Date Title
ATE258927T1 (de) Verbessertes verfahren zur herstellung von n- substituierte aminotetraline
DE60123615D1 (de) Verfahren zur herstellung von ultrahochreinem isopropanol
ATE259704T1 (de) Verfahren zur herstellung von formteilen
DE50000852D1 (de) Verfahren zur Herstellung von Aminen
DE50010110D1 (de) Verfahren zur herstellung von plattenförmigen produkten
DE69919412D1 (de) Verfahren zur herstellung von polyolefine
DE50003632D1 (de) Verfahren zur herstellung von l-phenylephrinhydrochlorid
DE69919408D1 (de) Verfahren zur herstellung von polyolefine
DE60006219D1 (de) Kontinuierliches verfahren zur herstellung von diacetoxybuten
DE60003264D1 (de) Verfahren zur herstellung von glycerylethern
DE50006772D1 (de) Verfahren zur herstellung von oxindolen
DE59914938D1 (de) Verfahren zur Herstellung von Gusswerkstücken
DE60039688D1 (de) Verfahren zur herstellung von uhrarmbandteilen
DE69916332D1 (de) Verfahren zur herstellung von etheraminalkoxylaten
ATE305958T1 (de) Verfahren zur herstellung von waschmitteln
DE50001895D1 (de) Verfahren zur herstellung von phosphonomethylglycin
DE50010478D1 (de) Verfahren zur herstellung von polyamiden
ATE233238T1 (de) Verfahren zur herstellung von 3-acyl-indolen
DE50008921D1 (de) Verfahren zur herstellung von blockweichschaumpolyolen
ATE295349T1 (de) Verfahren zur herstellung von ketiminen
DE60002260D1 (de) Verfahren zur Herstellung von Adamantanolen
DE60005417D1 (de) Verfahren zur Herstellung von Adamantanolen
ATE264829T1 (de) Verfahren zur herstellung von acylierten 1,3- dicarbonylverbindungen
DE50001448D1 (de) Verfahren zur herstellung von polyamiden
ATA45299A (de) Verfahren zur herstellung von oxcarbazepin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1232152

Country of ref document: EP